// App-Quantinova.ai

: Validation of 18F-Fluorodeoxyglucose Positron Emission Tomography as a Translational Biomarker to Support the Development of Novel Anti-fibrotic Drug Therapies

Researchers

Presenter

  • Juliana Maynard

Principal Investigators

  • Mary Mcelroy

  • Sally Price

  • Peter Simpson

Medical Centers

  • Medicines Discovery Catapult, Alderley Park, United Kingdom

  • Charles River Laboratories, Edinburgh (Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • 18F-fluorodeoxyglucose

Drug/Treatment

  • Bleomycin

  • Fludeoxyglucose (18F)

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved